Important translational implication of the findings is that thyroid cancer microvasculature may be a promising target for PSMA-directed treatment, especially in the subsets of RAI-refractory and aggressive high-grade thyroid carcinomas. This evidence concerns the gene FOLH1 and thyroid gland carcinoma.